(Q51097653)

29 March 2018

title

Optimism over vaccines administered via mucosal surfaces. (English)

1 reference

29 March 2018

author name string

M M Levine

series ordinal

1

1 reference

29 March 2018

G Dougan

series ordinal

2

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

29 March 2018

published in

The Lancet

1 reference

29 March 2018

volume

351

1 reference

29 March 2018

page(s)

1375-1376

1 reference

29 March 2018

issue

9113

1 reference

29 March 2018

Live oral cholera vaccine : from principle to product

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Intranasal booster vaccination against diphtheria and tetanus in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979439-3

7 January 2021

10.1016/S0140-6736(05)79439-3

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

9593404

1 reference

29 March 2018